Reimbursement of orphan drugs in Belgium: what (else) matters?

Abstract:

BACKGROUND:Most orphan drugs do not meet traditional standards of cost-effectiveness. Yet, most orphan drugs are reimbursed, which implies that other factors are taken into account at the time of reimbursement. To increase accountability of decision-makers, there is a need for more transparency in the factors that play a role in reimbursement decisions of orphan drugs. Therefore, the aim of this study is to use a combination of qualitative research methods to examine which official and non-official factors influence reimbursement decisions for orphan drugs in Belgium. METHODS:Six semi-structured interviews with past or present members of the Drug Reimbursement Committee (DRC) were performed with a view to obtaining an overview of the potential factors influencing reimbursement. Additionally, these presence of these factors was assessed in the reimbursement dossiers of all orphan drugs (n = 64) for which an application for reimbursement was submitted to the National Institute for Health and Disability Insurance in Belgium between January 2002 and July 2013. RESULTS:Different official (i.e. therapeutic value, budget impact, price and impact in clinical practice) and non-official factors (i.e. pricing and reimbursement in other countries, interference by patient organisations and experts, arguments related to quality of branded drug versus compounding, media attention, innovative character, economic importance, ethical arguments and the political climate) may have influenced past reimbursement decisions for orphan drugs in Belgium. DISCUSSION:The identification of factors influencing orphan drug reimbursement is a crucial step in the development of a transparent and consistent framework which will guide future decision-making for reimbursement of orphan drugs.

journal_name

Orphanet J Rare Dis

authors

Picavet E,Cassiman D,Simoens S

doi

10.1186/s13023-014-0139-z

subject

Has Abstract

pub_date

2014-09-12 00:00:00

pages

139

issn

1750-1172

pii

s13023-014-0139-z

journal_volume

9

pub_type

杂志文章
  • Erdheim-Chester Disease: a comprehensive review of the literature.

    abstract::Erdheim-Chester Disease (ECD) is a rare form of non Langerhans' cell histiocytosis. Individuals affected by this disease are typically adults between their 5th and 7th decades of life. Males and females are almost equally affected. The multi systemic form of ECD is associated with significant morbidity, which may aris...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-8-137

    authors: Mazor RD,Manevich-Mazor M,Shoenfeld Y

    更新日期:2013-09-08 00:00:00

  • Family burden in inherited ichthyosis: creation of a specific questionnaire.

    abstract:BACKGROUND:The concept of individual burden, associated with disease, has been introduced recently to determine the "disability" caused by the pathology in the broadest sense of the word (psychological, social, economic, physical). Inherited ichthyosis belong to a large heterogeneous group of Mendelian Disorders of Cor...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-8-28

    authors: Dufresne H,Hadj-Rabia S,Méni C,Sibaud V,Bodemer C,Taïeb C

    更新日期:2013-02-15 00:00:00

  • Suggested guidelines for the diagnosis and management of urea cycle disorders.

    abstract::Urea cycle disorders (UCDs) are inborn errors of ammonia detoxification/arginine synthesis due to defects affecting the catalysts of the Krebs-Henseleit cycle (five core enzymes, one activating enzyme and one mitochondrial ornithine/citrulline antiporter) with an estimated incidence of 1:8.000. Patients present with h...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-7-32

    authors: Häberle J,Boddaert N,Burlina A,Chakrapani A,Dixon M,Huemer M,Karall D,Martinelli D,Crespo PS,Santer R,Servais A,Valayannopoulos V,Lindner M,Rubio V,Dionisi-Vici C

    更新日期:2012-05-29 00:00:00

  • Oral epigallocatechin-3-gallate for treatment of dystrophic epidermolysis bullosa: a multicentre, randomized, crossover, double-blind, placebo-controlled clinical trial.

    abstract:UNLABELLED:Recessive dystrophic epidermolysis bullosa (RDEB) is a rare genodermatosis with severe blistering. No curative treatment is available. Scientific data indicated that epigallocatechin-3-gallate (EGCG), a green tea extract, might improve the phenotype of RDEB patients. In a multicentre, randomized, crossover, ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 信件,随机对照试验

    doi:10.1186/s13023-016-0411-5

    authors: Chiaverini C,Roger C,Fontas E,Bourrat E,Bourdon-Lanoy E,Labrèze C,Mazereeuw J,Vabres P,Bodemer C,Lacour JP

    更新日期:2016-03-25 00:00:00

  • The prevalence and epidemiology of genetic renal disease amongst adults with chronic kidney disease in Australia.

    abstract:BACKGROUND:There are an established and growing number of Mendelian genetic causes for chronic kidney disease (CKD) in adults, though estimates of prevalence have been speculative. The CKD Queensland (CKD.QLD) registry enables partial clarification of this through the study of adults with CKD receiving nephrology care ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-9-98

    authors: Mallett A,Patel C,Salisbury A,Wang Z,Healy H,Hoy W

    更新日期:2014-06-30 00:00:00

  • Haploinsufficiency of two histone modifier genes on 6p22.3, ATXN1 and JARID2, is associated with intellectual disability.

    abstract:BACKGROUND:Nineteen patients with deletions in chromosome 6p22-p24 have been published so far. The syndromic phenotype is varied, and includes intellectual disability, behavioural abnormalities, dysmorphic features and structural organ defects. Heterogeneous deletion breakpoints and sizes (1-17 Mb) and overlapping phen...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-8-3

    authors: Barøy T,Misceo D,Strømme P,Stray-Pedersen A,Holmgren A,Rødningen OK,Blomhoff A,Helle JR,Stormyr A,Tvedt B,Fannemel M,Frengen E

    更新日期:2013-01-07 00:00:00

  • Determinants of impaired quality of life in patients with fibrous dysplasia.

    abstract:BACKGROUND:Fibrous dysplasia is a rare bone disorder, commonly associated with pain, deformity and fractures, which may significantly impact on quality of life. In this study we evaluate quality of life in patients with fibrous dysplasia using the Short Form-36 and the Brief Pain Inventory questionnaires. Data were com...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-017-0629-x

    authors: Majoor BCJ,Andela CD,Bruggemann J,van de Sande MAJ,Kaptein AA,Hamdy NAT,Dijkstra PDS,Appelman-Dijkstra NM

    更新日期:2017-04-27 00:00:00

  • Patients with ACVR1R206H mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of Fibrodysplasia Ossificans Progressiva.

    abstract:BACKGROUND:Genetic contributors to cardiac arrhythmias are often found in cardiovascular conduction pathways and ion channel proteins. Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare disease of massive heterotopic ossification caused by a highly recurrent R206H mutation in ACVR1/ALK2. This mutation causes ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01465-x

    authors: Kou S,De Cunto C,Baujat G,Wentworth KL,Grogan DR,Brown MA,Di Rocco M,Keen R,Al Mukaddam M,le Quan Sang KH,Masharani U,Kaplan FS,Pignolo RJ,Hsiao EC

    更新日期:2020-07-29 00:00:00

  • Patient reported outcome measures in rare diseases: a narrative review.

    abstract:BACKGROUND:Rare diseases can lead to a significant reduction in quality of life for patients and their families. Ensuring the patients voice is central to clinical decision making is key to delivering, evaluating and understanding the efficacy of therapeutic interventions. Patient reported outcome measures (PROMs) are ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-018-0810-x

    authors: Slade A,Isa F,Kyte D,Pankhurst T,Kerecuk L,Ferguson J,Lipkin G,Calvert M

    更新日期:2018-04-23 00:00:00

  • How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration.

    abstract::Among the challenges confronting patients with rare diseases is a dearth of treatment options. The development of safe and effective new therapies is hampered by challenges associated with conducting clinical trials in small populations. In this article, we describe how the Duchenne muscular dystrophy community-led by...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-015-0281-2

    authors: Furlong P,Bridges JF,Charnas L,Fallon JR,Fischer R,Flanigan KM,Franson TR,Gulati N,McDonald C,Peay H,Sweeney HL

    更新日期:2015-06-24 00:00:00

  • Large homozygous RAB3GAP1 gene microdeletion causes Warburg micro syndrome 1.

    abstract::Warburg micro syndrome (WARBM) is a genetic heterogeneous disease characterized by microcephaly, intellectual disability, brain, ocular, and endocrine anomalies. WARBM1-4 can be caused by biallelic mutations of the RAB3GAP1 (RAB3 GTPase-activating protein 1), RAB3GAP2, RAB18 (RAS-associated protein RAB18), or TBC1D20 ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 信件

    doi:10.1186/s13023-014-0113-9

    authors: Picker-Minh S,Busche A,Hartmann B,Spors B,Klopocki E,Hübner C,Horn D,Kaindl AM

    更新日期:2014-10-21 00:00:00

  • Quality of life of children with achondroplasia and their parents - a German cross-sectional study.

    abstract:BACKGROUND:Achondroplasia is the most common form of disproportionate short stature and might affect not only the quality of life of the affected child but also that of the parents. OBJECTIVES:We aimed to investigate the quality of life of children with achondroplasia from child- and parent perspective as well as the ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1171-9

    authors: Witt S,Kolb B,Bloemeke J,Mohnike K,Bullinger M,Quitmann J

    更新日期:2019-08-09 00:00:00

  • The cumulative incidence and trends of rare diseases in South Korea: a nationwide study of the administrative data from the National Health Insurance Service database from 2011-2015.

    abstract:BACKGROUND:The burden of rare diseases on society and patients' families has increased in Korea. However, because of the infrequency of rare diseases, there is a lack of resources and information to address these cases and inadequate funding for the management of these patients. We investigated the average annual cumul...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1032-6

    authors: Lim SS,Lee W,Kim YK,Kim J,Park JH,Park BR,Yoon JH

    更新日期:2019-02-18 00:00:00

  • Disease awareness in myotonic dystrophy type 1: an observational cross-sectional study.

    abstract:BACKGROUND:Myotonic dystrophy type 1 (Steinert's disease or DM1), the most common form of autosomal dominant muscular dystrophy in adults, is a multisystem disorder, affecting skeletal muscle as well as eyes, heart, gastrointestinal tract, endocrine system, and central nervous system, finally responsible of increasing ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-016-0417-z

    authors: Baldanzi S,Bevilacqua F,Lorio R,Volpi L,Simoncini C,Petrucci A,Cosottini M,Massimetti G,Tognoni G,Ricci G,Angelini C,Siciliano G

    更新日期:2016-04-04 00:00:00

  • New insights into pediatric idiopathic pulmonary hemosiderosis: the French RespiRare(®) cohort.

    abstract:BACKGROUND:Idiopathic pulmonary hemosiderosis (IPH) is a rare cause of alveolar hemorrhage in children and its pathophysiology remains obscure. Classically, diagnosis is based on a triad including hemoptysis, diffuse parenchymal infiltrates on chest X-rays, and iron-deficiency anemia. We present the French pediatric co...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/1750-1172-8-161

    authors: Taytard J,Nathan N,de Blic J,Fayon M,Epaud R,Deschildre A,Troussier F,Lubrano M,Chiron R,Reix P,Cros P,Mahloul M,Michon D,Clement A,Corvol H,French RespiRare® group.

    更新日期:2013-10-14 00:00:00

  • Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis.

    abstract:BACKGROUND:Purine nucleoside analogs (PNAs) are the recommended first-line treatment for patients with hairy cell leukemia (HCL), but they are associated with adverse events (AEs). Due to a lack of real-world evidence regarding AEs that are associated with PNAs, we used commercial data to assess AE rates, AE-related he...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-1325-9

    authors: Epperla N,Pavilack M,Olufade T,Bashyal R,Li J,Kabadi SM,Yuce H,Andritsos L

    更新日期:2020-02-13 00:00:00

  • Arrhythmogenic cardiomyopathy.

    abstract::Arrhythmogenic cardiomyopathy (AC) is a heart muscle disease clinically characterized by life-threatening ventricular arrhythmias and pathologically by an acquired and progressive dystrophy of the ventricular myocardium with fibro-fatty replacement. Due to an estimated prevalence of 1:2000-1:5000, AC is listed among r...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-016-0407-1

    authors: Pilichou K,Thiene G,Bauce B,Rigato I,Lazzarini E,Migliore F,Perazzolo Marra M,Rizzo S,Zorzi A,Daliento L,Corrado D,Basso C

    更新日期:2016-04-02 00:00:00

  • Hamartomatous polyposis syndromes: a review.

    abstract::Hamartomatous Polyposis Syndromes (HPS) are genetic syndromes, which include Peutz-Jeghers syndrome, Juvenile polyposis syndrome, PTEN hamartoma tumour syndrome (Cowden Syndrom, Bannayan-Riley-Ruvalcaba and Proteus Syndrome) as well as hereditary mixed polyposis syndrome. Other syndromes such as Gorlin Syndrome and mu...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-9-101

    authors: Jelsig AM,Qvist N,Brusgaard K,Nielsen CB,Hansen TP,Ousager LB

    更新日期:2014-07-15 00:00:00

  • Differences in cardiac phenotype and natural history of laminopathies with and without neuromuscular onset.

    abstract:OBJECTIVE:To investigate differences in cardiac manifestations of patients affected by laminopathy, according to the presence or absence of neuromuscular involvement at presentation. METHODS:We prospectively analyzed 40 consecutive patients with a diagnosis of laminopathy followed at a single centre between 1998 and 2...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1245-8

    authors: Ditaranto R,Boriani G,Biffi M,Lorenzini M,Graziosi M,Ziacchi M,Pasquale F,Vitale G,Berardini A,Rinaldi R,Lattanzi G,Potena L,Martin Suarez S,Bacchi Reggiani ML,Rapezzi C,Biagini E

    更新日期:2019-11-19 00:00:00

  • Prevalence of Fabry disease in dialysis patients: Western Australia Fabry disease screening study - the FoRWARD study.

    abstract:AIM:To determine the prevalence of undiagnosed Fabry Disease (FD) in Western Australian (WA) patients undergoing dialysis. BACKGROUND:FD is a multisystem X-linked lysosomal storage disease caused by deficient activity of alpha-galactosidase-A (α-GAL-A). Affected individuals are at risk of developing small-fibre neurop...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1290-3

    authors: Jahan S,Sarathchandran S,Akhter S,Goldblatt J,Stark S,Crawford D,Mallett A,Thomas M

    更新日期:2020-01-13 00:00:00

  • Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability.

    abstract:BACKGROUND:A pattern of major and minor congenital anomalies, facial dysmorphic features, and neurodevelopmental difficulties, including cognitive and social impairments has been reported in some children exposed to sodium valproate (VPA) during pregnancy. Recognition of the increased risks of in utero exposure to VPA ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-019-1064-y

    authors: Clayton-Smith J,Bromley R,Dean J,Journel H,Odent S,Wood A,Williams J,Cuthbert V,Hackett L,Aslam N,Malm H,James G,Westbom L,Day R,Ladusans E,Jackson A,Bruce I,Walker R,Sidhu S,Dyer C,Ashworth J,Hindley D,Diaz G

    更新日期:2019-07-19 00:00:00

  • Urinary glutamine/glutamate ratio as a potential biomarker of pediatric chronic intestinal pseudo-obstruction.

    abstract::Chronic intestinal pseudo-obstruction (CIPO) is a rare intestinal motility disorder with significant morbidity and mortality in pediatric patients. The diagnosis of CIPO is difficult, because it is clinically based on the symptoms and signs of bowel obstruction which are similar to the clinical manifestations of other...

    journal_title:Orphanet journal of rare diseases

    pub_type: 信件

    doi:10.1186/s13023-017-0615-3

    authors: Yan JK,Zhou KJ,Huang JH,Wu QQ,Zhang T,Wang CC,Cai W

    更新日期:2017-03-28 00:00:00

  • Vici syndrome: a review.

    abstract::Vici syndrome [OMIM242840] is a severe, recessively inherited congenital disorder characterized by the principal features of callosal agenesis, cataracts, oculocutaneous hypopigmentation, cardiomyopathy, and a combined immunodeficiency. Profound developmental delay, progressive failure to thrive and acquired microceph...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-016-0399-x

    authors: Byrne S,Dionisi-Vici C,Smith L,Gautel M,Jungbluth H

    更新日期:2016-02-29 00:00:00

  • Oculocutaneous albinism.

    abstract::Oculocutaneous albinism (OCA) is a group of inherited disorders of melanin biosynthesis characterized by a generalized reduction in pigmentation of hair, skin and eyes. The prevalence of all forms of albinism varies considerably worldwide and has been estimated at approximately 1/17,000, suggesting that about 1 in 70 ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/1750-1172-2-43

    authors: Grønskov K,Ek J,Brondum-Nielsen K

    更新日期:2007-11-02 00:00:00

  • Moving towards effective therapeutic strategies for Neuronal Ceroid Lipofuscinosis.

    abstract::The Neuronal Ceroid Lipofuscinoses (NCLs) are a family of autosomal recessive neurodegenerative disorders that annually affect 1:100,000 live births worldwide. This family of diseases results from mutations in one of 14 different genes that share common clinical and pathological etiologies. Clinically, the diseases ar...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-016-0414-2

    authors: Geraets RD,Koh Sy,Hastings ML,Kielian T,Pearce DA,Weimer JM

    更新日期:2016-04-16 00:00:00

  • Rescue of fragile X syndrome phenotypes in Fmr1 KO mice by a BKCa channel opener molecule.

    abstract:BACKGROUND:Fragile X Syndrome (FXS) is the most common form of inherited intellectual disability and is also associated with autism spectrum disorders. Previous studies implicated BKCa channels in the neuropathogenesis of FXS, but the main question was whether pharmacological BKCa stimulation would be able to rescue FX...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-014-0124-6

    authors: Hébert B,Pietropaolo S,Même S,Laudier B,Laugeray A,Doisne N,Quartier A,Lefeuvre S,Got L,Cahard D,Laumonnier F,Crusio WE,Pichon J,Menuet A,Perche O,Briault S

    更新日期:2014-08-01 00:00:00

  • Clinical and biochemical characterization of four patients with mutations in ECHS1.

    abstract:BACKGROUND:Short-chain enoyl-CoA hydratase (SCEH, encoded by ECHS1) catalyzes hydration of 2-trans-enoyl-CoAs to 3(S)-hydroxy-acyl-CoAs. SCEH has a broad substrate specificity and is believed to play an important role in mitochondrial fatty acid oxidation and in the metabolism of branched-chain amino acids. Recently, t...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-015-0290-1

    authors: Ferdinandusse S,Friederich MW,Burlina A,Ruiter JP,Coughlin CR 2nd,Dishop MK,Gallagher RC,Bedoyan JK,Vaz FM,Waterham HR,Gowan K,Chatfield K,Bloom K,Bennett MJ,Elpeleg O,Van Hove JL,Wanders RJ

    更新日期:2015-06-18 00:00:00

  • Rare disease landscape in Brazil: report of a successful experience in inborn errors of metabolism.

    abstract::Brazil is a country of continental dimensions, with many social inequalities. The latter are reflected on its health system, which comprises a large public component called SUS, a small paid health insurance component and a third very small private component, in which patients pay personally for medical services. Seve...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章,评审

    doi:10.1186/s13023-016-0458-3

    authors: Giugliani R,Vairo FP,Riegel M,de Souza CF,Schwartz IV,Pena SD

    更新日期:2016-06-10 00:00:00

  • Correction to: Bisphosphonate therapy for spinal osteoporosis in Hajdu-Cheney syndrome - new data and literature review.

    abstract::After publication of this article [1], it is noticed reference no. 17 was incorrectly provided, details are shown below. ...

    journal_title:Orphanet journal of rare diseases

    pub_type: 已发布勘误

    doi:10.1186/s13023-019-1084-7

    authors: Pittaway JFH,Harrison C,Rhee Y,Holder-Espinasse M,Fryer AE,Cundy T,Drake WM,Irving MD

    更新日期:2019-05-10 00:00:00

  • Saccadic reaction time and ocular findings in phenylketonuria.

    abstract:BACKGROUND:Phenylketonuria (PKU) is an inherited metabolic disorder characterized by reduced activity of phenylalanine hydroxylase resulting in elevated blood phenylalanine (Phe) concentration. Despite some obvious ocular changes, the disorder has been poorly recognized by ophthalmologists. Neurophysiologic tests imply...

    journal_title:Orphanet journal of rare diseases

    pub_type: 杂志文章

    doi:10.1186/s13023-020-01407-7

    authors: Hopf S,Nowak C,Hennermann JB,Schmidtmann I,Pfeiffer N,Pitz S

    更新日期:2020-05-25 00:00:00